[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.241.171. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1986

Reduction of Pupillary Constriction During Cataract Surgery Using Suprofen

Author Affiliations

From the Wilmer Institute, Johns Hopkins Hospital, Baltimore (Dr Stark and Ms Klein); Dallas Ophthalmology Center (Dr Fagadau); Conner Glaucoma Center, The University of Texas Science Center, Houston (Dr Stewart); Division of Ophthalmology, University of Utah Medical Center, Salt Lake City (Dr Crandall); and the William C. Conner Research Center, Alcon Laboratories Inc, Fort Worth, Tex (Mr deFaller and Dr Reaves).

Arch Ophthalmol. 1986;104(3):364-366. doi:10.1001/archopht.1986.01050150064027
Abstract

• The efficacy of a new nonsteroidal anti-inflammatory agent, suprofen, for reducing pupillary constriction during cataract surgery was ascertained in a double-masked, multicenter, clinical study. Prior to surgery 1.0% suprofen or a placebo was instilled; the surgeon's normal regimen of mydriatics and cycloplegics was used. Suprofen (209 patients) was far more effective than the placebo (203 patients) in maintaining a dilated pupil prior to intraocular lens (IOL) implantation (or instillation of a miotic). The mean pupillary area prior to IOL implantation was 6.3 sq mm larger (20% larger) in patients treated with suprofen than in patients receiving the placebo. The investigators' subjective evaluations of the adequacy of pupil size for IOL implantation and of the difficulty of IOL implantation favored patients treated with suprofen over those receiving the placebo.

References
1.
Duffin RM, Camras CB, Gardner SK, et al:  Inhibitors of surgically induced miosis . Ophthalmology 1982;89:966-979.Article
2.
Keulen-DeVos HCJ, Van Rij G, Renardel De Lavalette JCG, et al:  Effect of indomethacin in preventing surgically induced miosis . Br J Ophthalmol 1983;67:94-96.Article
3.
Kulkarni PS, Srinivasan BD:  Steroidal and nonsteroidal anti-inflammatory drugs in ocular inflammation . Ocular Inflammation Ther 1983; 1:11-18.
4.
Miyake K, Sugiyama S, Norimatsu I, et al:  Prevention of cystoid macular edema after lens extraction by topical indomethacin: III. Radioimmunoassay measurements of prostaglandins in the aqueous during and after lens extraction procedures . Graefes Arch Clin Exp Ophthalmol 1978;209:83-88.Article
5.
Kremer M, Baikoff G, Charbonnel B:  Prostaglandin E2 in side effects of ocular surgery in man: Preventative action of indomethacin , in Samuelsson R, Paoletti R, Ramwell P (eds): Advances in Prostaglandin, Thromboxane, and Leukotrine Research . New York, Raven Press, 1983, vol 12, pp 121-126.
6.
Kulkarni PS, Eakins HM, Saber WL, et al:  Microsomal preparations of normal bovine irisciliary body generate prostacyclin-like but not thromboxane-A2-activity . Prostaglandins 1977; 14:689-700.Article
7.
Kulkarni PS:  Synthesis of cyclooxygenase products by human anterior uvea from cyclic prostaglandin endoperoxidase (PGH2) . Exp Eye Res 1981;32:197-204.Article
8.
Keates RH, McGowan KA:  Clinical trial of flurbiprofen to maintain pupillary dilation during cataract surgery . Ann Ophthalmol 1984; 16:919-921.
9.
Sawa M, Masuda K:  Topical indomethacin in soft cataract aspiration . Jpn J Ophthalmol 1976; 20:514-519.
10.
Keates RH, McGowan KA:  The effect of topical indomethacin ophthalmic solution in maintaining mydriasis during cataract surgery . Ann Ophthalmol 1984;16:1116-1121.
11.
Klug RD, Krohn DL, Breitfeller JM, et al:  Inhibition of trauma-induced miosis by indoxole . Ophthalmic Res 1981;13:122-128.Article
12.
Capetola RJ, Argentieri D, Weintraub HS, et al:  Suprofen , in Goldberg ME (ed): Pharmacological and Biochemical Properties of Drug Substances . Washington, DC, American Pharmaceutical Association Academy of Pharmaceutical Sciences, 1981, vol 3, pp 347-368.
13.
Datiles MB, Stark WJ, Fagadau WR, et al: Pseudophakic CME: Clinical trial of a new topical prostaglandin synthetase inhibitor. Ophthalmic Surg, in press.
14.
Aoki KR, DeSantis L:  Ocular anti-inflammatory activity of topically administered suprofen solution in New Zealand albino rabbits . Invest Ophthalmol Vis Sci 1984;25( (suppl) ):336.
15.
Lee BP, Kupferman A, Leibowitz HM:  Effect of suprofen on corneal wound healing . Arch Ophthalmol 1985;103:95-97.Article
16.
Eakins KE, Whitelocke RAF, Perkins ES, et al:  Release of prostaglandin in ocular inflammation in the rabbit . Nature 1972;239:248-249.Article
17.
Bhattacherjee P:  Release of prostaglandinlike substances by Shigella endotoxin and its inhibition by non-steroidal anti-inflammatory compounds . Br J Pharmacol 1975;54:489-494.Article
18.
Srinivasan B, Kulkarni P, Eakins K:  Characterization of chemotactic factors in corneal wound healing , in Samuelsson B, Ramwell P, Paoletti R (eds): Advances in Prostaglandin and Thromboxane Research . New York, Raven Press, 1980, vol 7, p 861.
19.
Eakins K:  Prostaglandins and the eye , in Karim S (ed): The Prostaglandins: Physiological, Pharmacological, and Pathological Aspects . Baltimore, University Park Press, 1976, p 63.
20.
Product monograph, Document 276-a, 5, 83, Indocid Ophthalmic Suspension. Kirkland, Quebec, Merck, Sharp & Dohme Division of Merck Frosst Canada Inc, 1983.
21.
Hillman JS, Frank GJ, Kheskani MB:  Flurbiprofen and human intraocular inflammation , in Samuelsson B, Ramwell P, Paoletti R (eds): Advances in Prostaglandin and Thromboxane Research . New York, Raven Press, 1980, vol 8, pp 1723-1726.
×